Lv5
1070 积分 2024-05-27 加入
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
22小时前
待确认
Draft Document for Public Consultation: iCARDIO Alliance Global Implementation Guidelines on Obesity Management 2025
6天前
已完结
Recent discoveries on the acquisition of the highest levels of human performance
14天前
已完结
A facile approach to construct hyaluronic acid shielding polyplexes with improved stability and reduced cytotoxicity
2个月前
已完结
Tat-conjugated hyaluronic acid enveloping polyplexes with facilitated nuclear entry and improved transfection
2个月前
已完结
Modification of PEI with cyclodextrin as a tool for better understanding the major barriers for DNA delivery
2个月前
已完结
Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials
2个月前
已完结
Obesity in China: current progress and future prospects
2个月前
已完结
Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD
2个月前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
3个月前
已完结
皖公网安备34019202002308
